Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 25 March 2008
Vol. 1, Issue 12, p. ec113
[DOI: 10.1126/stke.112ec113]

EDITORS' CHOICE

Medicine Faulty Scaffolding and Cancer

Paula A. Kiberstis

Science, AAAS, Washington, DC 20005, USA

Differentiation, survival, and growth of B cells requires proper functioning of the nuclear factor {kappa}B (NF-{kappa}B) signaling pathway, including CARD11, a cytoplasmic scaffolding protein that serves as a docking site for signaling molecules. Lenz et al. have discovered that a certain subtype of diffuse large B cell lymphoma (DLBCL), the most common form of non-Hodgkin’s lymphoma in humans, is caused by mutations in the CARD11 gene. In cell culture experiments, these mutant forms of CARD11 caused inappropriate activation of the NF-{kappa}B pathway.

G. Lenz, R. E. Davis, V. N. Ngo, L. Lam, T. C. George, G. W. Wright, S. S. Dave, H. Zhao, W. Xu, A. Rosenwald, G. Ott, H. K. Muller-Hermelink, R. D. Gascoyne, J. M. Connors, L. M. Rimsza, E. Campo, E. S. Jaffe, J. Delabie, E. B. Smeland, R. I. Fisher, W. C. Chan, L. M. Staudt, Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676-1679 (2008). [Abstract] [Full Text]

Citation: P. A. Kiberstis, Faulty Scaffolding and Cancer. Sci. Signal. 1, ec113 (2008).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882